• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳腺细胞系(HBL-100)中的纤溶酶原激活剂及其抑制剂。糖皮质激素的调节作用。

Plasminogen activators and their inhibitors in a human mammary cell line (HBL-100). Modulation by glucocorticoids.

作者信息

Busso N, Belin D, Failly-Crépin C, Vassalli J D

出版信息

J Biol Chem. 1986 Jul 15;261(20):9309-15.

PMID:3087993
Abstract

Culture of human mammary HBL-100 cells in the presence of dexamethasone, a synthetic glucocorticoid, resulted in opposite effects on the production of the two plasminogen activators (PAs): a decrease in urokinase-type PA (u-PA) and a concomitant increase in tissue-type PA (t-PA). Two PA-specific inhibitors, one related to that produced by bovine aortic endothelial cells, and the other related to that isolated from human placenta, were also produced by these cells; dexamethasone did not affect the production of either of these inhibitors. The glucocorticoid effects observed on PA enzymatic activities were associated with changes in PA mRNA levels. Experiments using inhibitors of RNA and protein synthesis suggested that the glucocorticoid-induced decrease in u-PA mRNA was a secondary event, requiring synthesis of new regulatory proteins; in contrast, the increase in t-PA mRNA appeared to be a direct effect on t-PA gene expression.

摘要

在合成糖皮质激素地塞米松存在的情况下培养人乳腺HBL - 100细胞,对两种纤溶酶原激活剂(PA)的产生产生了相反的影响:尿激酶型PA(u - PA)减少,同时组织型PA(t - PA)增加。这些细胞还产生了两种PA特异性抑制剂,一种与牛主动脉内皮细胞产生的抑制剂相关,另一种与从人胎盘中分离出的抑制剂相关;地塞米松不影响这两种抑制剂中任何一种的产生。观察到的糖皮质激素对PA酶活性的影响与PA mRNA水平的变化有关。使用RNA和蛋白质合成抑制剂的实验表明,糖皮质激素诱导的u - PA mRNA减少是一个次级事件,需要合成新的调节蛋白;相反,t - PA mRNA的增加似乎是对t - PA基因表达的直接影响。

相似文献

1
Plasminogen activators and their inhibitors in a human mammary cell line (HBL-100). Modulation by glucocorticoids.人乳腺细胞系(HBL-100)中的纤溶酶原激活剂及其抑制剂。糖皮质激素的调节作用。
J Biol Chem. 1986 Jul 15;261(20):9309-15.
2
Glucocorticoid modulation of plasminogen activators and of one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231.糖皮质激素对人乳腺癌细胞系MDA-MB-231中纤溶酶原激活剂及其一种抑制剂的调节作用。
Cancer Res. 1987 Jan 15;47(2):364-70.
3
Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts.凝血酶对人胎儿肺成纤维细胞中组织型和尿激酶型纤溶酶原激活剂基因的转录调控
Thromb Haemost. 1995 Aug;74(2):704-10.
4
Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2.糖皮质激素对组织型和尿型纤溶酶原激活物以及纤溶酶原激活物抑制剂1和2基因表达的调节作用
J Cell Biol. 1988 Mar;106(3):971-8. doi: 10.1083/jcb.106.3.971.
5
Plasminogen activator regulation in osteoblasts: parathyroid hormone inhibition of type-1 plasminogen activator inhibitor and its mRNA.成骨细胞中纤溶酶原激活物的调节:甲状旁腺激素对1型纤溶酶原激活物抑制剂及其mRNA的抑制作用
J Cell Physiol. 1992 Aug;152(2):346-55. doi: 10.1002/jcp.1041520216.
6
Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.利用单克隆抗体对人肿瘤细胞系中细胞外纤溶酶原激活剂及分子量约为54,000的纤溶酶原激活剂抑制剂的激素调节作用进行研究。
Mol Cell Endocrinol. 1986 May;45(2-3):137-47. doi: 10.1016/0303-7207(86)90141-3.
7
Regulation and secretion of plasminogen activators and their inhibitors in a human leukemic cell line (K562).人白血病细胞系(K562)中纤溶酶原激活剂及其抑制剂的调节与分泌
Blood. 1989 Sep;74(4):1321-7.
8
Characterization of recombinant plasminogen activator production by primate endothelial cells transduced with retroviral vectors.
Blood. 1994 Jul 15;84(2):504-16.
9
Glucocorticoid regulation of plasminogen activator inhibitor-1 messenger ribonucleic acid and protein in normal and malignant rat osteoblasts.糖皮质激素对正常及恶性大鼠成骨细胞中纤溶酶原激活物抑制剂-1信使核糖核酸和蛋白质的调控
Endocrinology. 1992 Feb;130(2):797-804. doi: 10.1210/endo.130.2.1733726.
10
Alveolar epithelial cell plasminogen activator. Characterization and regulation.
J Biol Chem. 1990 May 15;265(14):8198-204.

引用本文的文献

1
Glucocorticoid (GC)-mediated down-regulation of urokinase plasminogen activator expression via the serum and GC regulated kinase-1/forkhead box O3a pathway.糖皮质激素(GC)通过血清和糖皮质激素调节激酶-1/叉头框O3a途径介导尿激酶型纤溶酶原激活剂表达的下调。
Endocrinology. 2008 May;149(5):2637-45. doi: 10.1210/en.2007-1096. Epub 2008 Jan 31.
2
Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury.纤溶酶原激活物抑制剂-1在急性高氧小鼠肺损伤中的作用
J Clin Invest. 1996 Dec 15;98(12):2666-73. doi: 10.1172/JCI119089.
3
Protease-nexin I as an androgen-dependent secretory product of the murine seminal vesicle.
蛋白酶连接素I作为小鼠精囊的雄激素依赖性分泌产物。
EMBO J. 1993 May;12(5):1871-8. doi: 10.1002/j.1460-2075.1993.tb05835.x.
4
Dexamethasone decreases urokinase plasminogen activator mRNA stability in MAT 13762 rat mammary carcinoma cells.地塞米松降低MAT 13762大鼠乳腺癌细胞中尿激酶型纤溶酶原激活物的mRNA稳定性。
Br J Cancer. 1993 Jan;67(1):99-101. doi: 10.1038/bjc.1993.16.
5
Upregulation of urokinase receptor expression on migrating endothelial cells.迁移内皮细胞上尿激酶受体表达上调。
J Cell Biol. 1993 Aug;122(3):673-84. doi: 10.1083/jcb.122.3.673.
6
Activities, localizations, and roles of serine proteases and their inhibitors in human brain tumor progression.丝氨酸蛋白酶及其抑制剂在人脑肿瘤进展中的活性、定位和作用
J Neurooncol. 1994;22(2):139-51. doi: 10.1007/BF01052889.
7
Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2.糖皮质激素对组织型和尿型纤溶酶原激活物以及纤溶酶原激活物抑制剂1和2基因表达的调节作用
J Cell Biol. 1988 Mar;106(3):971-8. doi: 10.1083/jcb.106.3.971.
8
Plasminogen activator and mouse spermatozoa: urokinase synthesis in the male genital tract and binding of the enzyme to the sperm cell surface.纤溶酶原激活物与小鼠精子:雄性生殖道中尿激酶的合成以及该酶与精子细胞表面的结合。
J Cell Biol. 1987 May;104(5):1281-9. doi: 10.1083/jcb.104.5.1281.
9
Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors.γ干扰素增强巨噬细胞中肿瘤坏死因子/恶病质素、白细胞介素1和尿激酶基因的转录,这些基因受短命阻遏物的调控。
J Exp Med. 1986 Dec 1;164(6):2113-8. doi: 10.1084/jem.164.6.2113.
10
Mouse ovarian granulosa cells produce urokinase-type plasminogen activator, whereas the corresponding rat cells produce tissue-type plasminogen activator.小鼠卵巢颗粒细胞产生尿激酶型纤溶酶原激活物,而相应的大鼠细胞产生组织型纤溶酶原激活物。
J Cell Biol. 1987 Aug;105(2):977-81. doi: 10.1083/jcb.105.2.977.